Clinical Outcomes of 100% Glistening Free Intraocular Lens Implantation

Authors : Hasan Ali Bayhan, Koçer Furkan Durukan, Seray Aslan, Eyüp Erkan
Pages : 139-147
Doi:10.16919/bozoktip.1547782
View : 50 | Download : 28
Publication Date : 2025-06-15
Article Type : Research Paper
Abstract :Objective: The purpose of this study is to investigate the outcomes of ENOVA GF3 intraocular lens (IOL) implantation. Materials and Methods: In this retrospective study, we evaluated the clinical results of patients undergoing phacoemulsification and implanted ENOVA GF3, a hydrophobic acrylic IOL, in XXXX ophthalmology clinic. 320 eyes of 292 patients were included in the study. All operations were performed by the same surgeon. The postoperative follow-up examinations were conducted on the 1 st and 7 th postoperative days and at the 1 st , 3 rd , 6 th and 12 th months. In these examinations, we examined uncorrected distance visual acuity, corrected distance visual acuity, uncorrected and corrected near visual acuity. Photographs of the anterior segment were taken after pupil dilation, Glistening and posterior capsule opacification (PCO) formations were noted. Deviations from the target refraction were determined by postoperative autorefractometer values. The patients underwent contrast sensitivity tests. All patients’ quality of life was determined with the National Eye Institute-Visual Function Questionnaire (NEI VFQ 25). Results: In 282 eyes (88%) the mean incision size was 2.20 and in 38 eyes (12%) it was 2.80 mm. In terms of intraoperative complications, intraoperative floppy iris (IFIS) occurred in 3 patients (0.01%) and posterior capsule rupture (PCR) occurred in 1 patient (0.003%). Evaluations at 6 and 12 months showed no glistening, PCO or any other complications. The target refraction deviation values were 0.06 ± 0.71 and the mean corrected visual acuity was 0.98 ± 20 at the 12-month evaluation after IOL implantation. Conclusion: It was found that the ENOVA GF3 IOL was a safe lens in terms of intraoperative complications, postoperative fibrin reaction, deviation from target refraction, PCO and glistening. Considering the short- and long-term results of ENOVA GF3, we suggest that it can be preferred in clinical practice.
Keywords : göziçi lens, ENOVA GF3, hidrofobik lens, katarakt

ORIGINAL ARTICLE URL